Table 4.
AP |
BP |
|||||||
---|---|---|---|---|---|---|---|---|
Univariate | Multivariate | Univariate | Multivariate | |||||
HR | P | HR | P | HR | P | HR | P | |
Age, y | 1.02 | .002 | 1.02 | .02 | 1.01 | .22 | 1.01 | .04 |
Male sex | 1.10 | .65 | 1.97 | .004 | 0.89 | .39 | 0.79 | .18 |
Splenomegaly | 1.86 | .01 | 1.51 | .17 | 1.04 | .82 | 1.004 | .98 |
Hemoglobin, g/dL | 1.04 | .38 | 1.09 | .26 | 1.03 | .31 | 1.06 | .12 |
White blood cell counts × 109/L | 1.01 | .35 | 0.999 | .32 | 0.999 | .96 | 1.000 | .94 |
Platelet count × 109/L | 1.002 | .51 | 1.000 | .55 | 0.999 | .005 | 0.999 | .006 |
Peripheral blasts, % | 1.03 | .009 | 0.98 | .16 | 1.01 | < .001 | 1.005 | .15 |
Peripheral basophils, % | 0.98 | .10 | 0.98 | .17 | 0.99 | .19 | 0.99 | .20 |
BM blasts, % | 1.05 | < .001 | 1.07 | < .001 | 1.003 | .16 | 0.997 | .46 |
BM basophils, % | 0.99 | .56 | 1.06 | .04 | 0.99 | .36 | 1.02 | .2 |
Y of therapy | 0.947 | < .001 | 0.93 | < .001 | 0.97 | < .001 | 0.956 | < .001 |